Labcyte

BLOG

FRIDAY, SEPTEMBER 16, 2016

EDITORIAL: We Can Save More Cancer Patients Right Now

In a commentary just published in Drug Discovery & Development magazine, Labcyte CEO Mark Fischer-Colbrie discusses the opportunity to save more cancer patients through individualized medicine.
Read More

WEDNESDAY, SEPTEMBER 14, 2016

Fall Conference Season Kicks Off with MipTec and Festival of Genomics

Next week is a busy one for the Labcyte team, with two great conferences taking place in Europe and the U.S.

Read More

TUESDAY, SEPTEMBER 06, 2016

Biocompare Spotlights Advances in High-Throughput Screening

Biocompare recently posted an article about high-throughput screening, and Labcyte is featured in the coverage.
Read More

MONDAY, AUGUST 29, 2016

What Science Can Do – Labcyte and AstraZeneca

Our partners at AstraZeneca have a nice profile on their website that talks about our collaboration to create an acoustically loaded mass spec platform, and why they chose to invest in the Labcyte Echo technology. The goal of this work is to expand the utility of mass spectrometry for high-throughput, low-cost, label-free analysis. As you may recall, this product won the SLAS Innovation Award in 2015!
Read More

TUESDAY, AUGUST 09, 2016

DDW Magazine Interviews Labcyte Customer Chris Voigt of MIT about Synthetic Biology

The summer issue of Drug Discovery World magazine contains a great interview about synthetic biology with our customer Chris Voigt, a professor of biological engineering at MIT.
Read More

FRIDAY, JUNE 10, 2016

ARTICLE: Individualized Medicine vs. Precision Medicine - DDNews

There are people who will die of cancer this week even though there are drugs that could help them. At the same time, hundreds of patients will undergo cancer chemotherapy that, while debilitating and expensive, will not cure them of their disease.
Read More

THURSDAY, JUNE 09, 2016

WEBINAR: Enabling Cancer Research with Echo Acoustic Liquid Handlers: a PI3K Pathway Case Study

Class I Phosphoinositide 3-kinase (PI3K) proteins have been extensively characterized with respect to their roles in cell proliferation and tumorigenesis, and serve as highly sought-after targets for oncogenic drug development. Labcyte Sr. Applications Scientist Linda Orren will present a series of experiments, all of which target some aspect of the PI3K pathway. These case studies will highlight specifics of assay development and miniaturization that are uniquely enabled by Echo Acoustic Liquid Handlers.
Read More